← Back to Drugs A–Z

Zopiclone, Zaleplon and Zolpidem

Group: Depressants
Nicknames: Z-drugs, Ambien, Stilnox, Imovane, Zimovane, Sonata, eszopiclone, Lunesta, zimmos, zees
Last reviewed: October 2026

History

‘Z-drugs’ emerged in the last years of the 1980s and early 1990s, with zopiclone (Zimovane) approved by the NHS in 1989, followed by zolpidem (Ambien) manufactured by the Sanofi Group. By 1999, the last of the group, zaleplon, was introduced to the clinical pharmacopeia. As concern of the potential for dependence formation and management of chronic insomnia rose, the Z group became increasingly popular. As may have been anticipated by students of the history of hypnotics, a debate over the dependence liability of the ‘Z-drugs’ has also developed across the years. Despite being marketed as a ‘safer alternative’ to benzos, Z-drugs appear to produce similar rates of dependence and protracted withdrawals among individuals who take them long-term.

In 2020, researchers Hockenhull and colleagues found that the non-prescribed use of Z drugs was more common among people who use heroin, compared to benzos being more common among people who use stimulants. In recent years, some benzos including bromazolam and diazepam have been missold as Z-drugs (most commonly sold as zolpidem), likely due to their mode of action.

Keep This Information Independent

Release is a registered charity. We rely on your support to provide expert, non-judgmental legal and harm reduction guidance to thousands of people every year.

Donate to Release